Publication Scheme of Advisory Board on the Registration of Homoeopathic Products

Prepared under section 19 of the Freedom of Information Act 2000

Introduction
The Freedom of Information (FOI) Act (the 'Act') asserts the right of individuals to obtain access to official information to the greatest extent possible consistent with the public interest and the need to protect legitimate confidential information. The Advisory Board on the Registration of Homoeopathci Products (ABRHP) currently makes information routinely available to the public in relation to its functions, membership and meetings. Such information will continue to be available without the need to use the FOI Act. This document highlights, in relation to the ABRHP's activities, where information of this nature is available.

The FOI Act is designed to allow public access to information held by public bodies which is not routinely available from other sources. Access to information under the Act is subject to certain exemptions and involves specific procedures and time limits, which are outlined in the Medicines and Healthcare products Regulatory Agency (MHRA)'s Publication Scheme.

The role of the Advisory Board on the Registration of Homoeopathic Products
The Advisory Board on the Registration of Homoeopathic Products (ABRHP) was established in 1994 under section 4 of the Medicines Act 1968. It advises UK Ministers on the safety and quality of any homoeopathic medicinal product for human use in respect of which a certificate of registration could be granted. Information about the definition of a homoeopathic product and the legislation covering the current registration scheme is available on the MHRA website at www.mhra.gov.uk

The ABRHP also advises on veterinary medicines.

Responsibility for the Publication Scheme
The Director of the Executive Support Division of the Medicines and Healthcare products Regulatory Agency (MHRA) has overall responsibility for the ABRHP's Publication Scheme. Ms Jane Viner, Manager, Medicines Information and Web Services, is the individual having day-to-day responsibility maintaining the scheme.

Classes of information included in the Advisory Board on the Registration of Homoeopathic Products' Publication Scheme 
 

Classes including definitions where appropriate

Information in this class is available in the following formats

£ indicates that this class includes chargeable material

Role and conduct of the ABRHP; the role and code of conduct of the ABRHP.

Hard copy by contacting 020 7084 2000; MHRA website www.mhra.gov.uk

 

Membership, declarations of interest and fees paid to members.

as above

 

Annual report.

as above

£ (hard copy)

Minutes of meetings: summary minutes edited to protect personal and commercial confidentiality of ABRHP meetings.

as above

  
Dates of future ABRHP as above  
Background information on homoeopathic medicines and the registration scheme, including application form as above  

Details of granted homoeopathic products and an updated list of granted certificates

as above

  



Page last modified: 05 October 2005